Association of repeat polymorphisms in the estrogen receptors alpha, beta (ESR1, ESR2) and androgen receptor (AR) genes with the occurrence of breast cancer

Breast

Volumn 17, Issue 2, 2008, Pages 159-166

  Tsezou, A ^a   Tzetis, M ^b   Gennatas, C ^c   Giannatou, E ^d   Pampanos, A ^b   Malamis, G ^b   Kanavakis, E ^b   Kitsiou, S ^b  

^a UNIVERSITY OF THESSALY   (Greece)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^c UNIVERSITY OF ATHENS   (Greece)

^d UNIVERSITY OF ATHENS   (Greece)

Author keywords

Breast cancer; Estrogen androgen receptors; Repeat polymorphisms; Steroid hormones

Indexed keywords

ADENOSINE; ANDROGEN RECEPTOR; CYTOSINE; ESTROGEN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; GENOMIC DNA; GUANOSINE; TYROSINE;

ADULT; AGED; ARTICLE; BODY MASS; BREAST CANCER; CANCER RISK; CASE CONTROL STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; ESTROGEN THERAPY; FAMILY HISTORY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MENARCHE; MENOPAUSE; PRIORITY JOURNAL; TUMOR VOLUME;

EID: 41549140086     PISSN: 09609776     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.breast.2007.08.007     Document Type: Article

References (38)

1. Wiemann R.A. Breast cancer hypothesis: a single cause for the majority of cases. J Epidemiol Community Health 54 (2000) 851-858
2. Lacroix M., and Leclercq G. The "portrait" of hereditary breast cancer. Breast Cancer Res Treat 89 (2005) 297-304
3. Lichtenstein P., Holm N.V., Verkasalo P.K., et al. Environmental and heritable factors in the causation of cancer-analyses of cohorts of twins from Sweden, Denmark and Finland. N Eng J Med 343 (2000) 78-85
4. Zheng S.L., Zheng W., Chang B., et al. Joint effect of estrogen receptor β sequence variants and endogenous estrogen exposure on breast cancer risk in Chinese women. Cancer Res 63 (2003) 7624-7629
5. Roodi N., Bailey L.R., Cao W.Y., et al. Estrogen receptor gene analysis in estrogen receptor positive and receptor negative primary breast cancer. J Natl Cancer Inst 87 (1995) 446-451
6. Ingles S.A., Ross R.K., Yu M.C., et al. Association of prostate cancer risk with genetic polymorphisms in vitamin D receptor and androgen receptor. J Natl Cancer Inst 89 (1977) 166-170
7. Ascenzi P., Bocedi A., and Marino M. Structure-function relationship of estrogen receptor α and β: impact on human health. Mol Aspects Med 27 (2006) 299-402
8. Ponglikitmongkol M., Green S., and Chambon P. Genomic organisation of the human oestrogen receptor gene. EMBO J 7 (1988) 3385-3388
9. Enmark E., Pelto-Huikko M., Grandien K., et al. Human estrogen receptor β-gene structure, chromosomal localization and expression pattern. J Clin Endocrinol Metab 82 (1977) 4258-4265
10. Iwase H., Greenman J.M., Barnes D.M., Hodgson S., Bobrow L., and Matthew C.G. Sequence variants of the estrogen receptor (ER) gene found in breast cancer patients with ER negative and progesterone receptor positive tumors. Cancer Lett 108 (1996) 179-184
11. Picard D., Bunone G., Liu J.W., and Donzw O. Steroid independent activation of steroid receptors in mammalian and yeast cells and in breast cancer. Biochem Soc Trans 25 (1997) 597-602
12. Menin C., Banna G.L., De Salvo G., et al. Lack of association between androgen receptor CAG polymorphism and familial breast/ovarian cancer. Cancer Lett 168 (2001) 31-36
13. Maggiolini M., Donze O., Jeannin E., et al. Adrenal androgens stimulate the proliferation of breast cancer cells as direct activation of estrogen receptor α. Cancer Res 59 (1999) 4864-4869
14. Cox D., Blanche H., Pearce C.L., et al. A comprehensive analysis of the androgen receptor gene and risk of breast cancer: results from the National Cancer Insitute Breast and Prostate Cancer Cohort Consortium (BPC3). Breast Cancer Res 8 (2006) R54
15. Zhang W., and Yu Y.Y. Polymorphisms of short tandem repeat of genes and breast cancer susceptibility. EJSO 33 (2007) 529-534
16. Rebbeck T.R., Kantoff P.W., Krithivas K., et al. Modification of the BRCA1 associated breast cancer risk by the polymorphic androgen receptor CAG repeat. Am J Hum Genet 64 (1999) 1371-1377
17. Spurdle A.B., Dite G.S., Chen X., et al. Androgen receptor exon 1 CAG repeat length and breast cancer in women before age forty years. J Natl Cancer Inst 91 (1999) 961-966
18. Sprudle A.B., Antoniou A., Duffy D.L., et al. The androgen receptor CAG repeat polymorphism and modification of breast cancer risk in BRCA1 and BRCA2 mutation carriers. Breast Cancer Res 7 (2005) R176-R183
19. Given H.F., Radbourne R., Oag H., et al. The androgen receptor exon 1 trinucleotide repeat does not act as a modifier of the age of presentation in breast cancer. Eur J Cancer 36 (2000) 533-534
20. DeAbreu F.B., Picolo L.J., Canevari R.A., et al. Shorter CAG repeat in the AR gene is associated with atypical hyperplasia and breast carcinoma. Anticancer Res 27 (2007) 1199-1205
21. Henderson B.E., and Feigelson H.S. Hormonal carcinogenesis. Carcinogenesis 21 (2000) 427-433
22. Russo J., Hu Y.F., Yang X., and Russo I.H. Developmental, cellular, and molecular basis of human breast cancer. J Natl Cancer Inst Monogr 27 (2000) 17-37
23. Becherini L., Gennari L., Masi L., et al. Evidence of a linkage disequilibrium between polymorphisms in the human estrogen receptor alpha gene and their relationship to bone mass variation in postmenopausal Italian women. Hum Mol Genet 9 (2000) 2043-2050
24. Fytili P., Giannatou E., Papanikolaou V., et al. Association of repeat polymorphisms in the estrogen receptors alpha, beta, and androgen receptor genes with knee osteoarthritis. Clin Genet 68 (2005) 268-277
25. Rothenburg S., Koch-Nolte F., Rich A., and Haag F. A polymorphic dinucleotide repeat in the rat nucleolin gene forms Z-DNA and inhibits promoter activity. Proc Natl Acad Sci 98 (2001) 8985-8990
26. Yeap B.B., Wilce J.A., and Leedman P.J. The androgen receptor mRNA. BioEssays 26 (2004) 672-682
27. Westberf L., Baghaei F., Rosmond R., et al. Polymorphisms of the Androgen receptor gene and the estrogen receptor β gene are associated with androgen levels in women. J Clin Endocrinol Metabol 86 (2001) 2562-2568
28. Maguire P., Margolin S., Skoglund J., et al. Estrogen receptor beta (ESR2) polymorphisms in familial and sporadic breast cancer. Breast Cancer Res Treat 94 (2005) 145-152
29. Giguere Y., Dewailly E., Brisson J., et al. Short polyglutamine tracts in the androgen receptor are protective against breast cancer in the general population. Cancer Res 61 (2001) 5869-5874
30. Haiman C.A., Bernstein L., Berg D., Ingles S.A., Salane M., and Ursin G. Genetic determinants of mammographic density. Breast Cancer Res 4 (2002) R5
31. Dunning A.M., Healey C.S., Pharoah P.D., Teaie M.D., Ponder B.A., and Easton D.F. A systematic review of genetic polymorphisms and breast cancer risk. Cancer Epidemiol Biomarkers Prev 8 (1999) 843-854
32. Kaduri L., Easton D.F., Edwards S., et al. CAG and GGC repeat polymorphisms in the androgen receptor gene and breast cancer susceptibility in BRCA1/2 carriers and non-carriers. Br J Cancer 85 (2001) 36-40
33. n polymorphisms and breast cancer risk in population-based case-control study of young women. Cancer Epidemiol Biomarkers Prev 12 (2003) 127-135
34. Liede A., Zhang W., De Leon Matsuda M.L., Tan A., and Narod S.A. Androgen receptor gene polymorphism and breast cancer susceptibility in the Philippines. Cancer Epidemiol Biomarkers Prev 12 (2003) 848-852
35. Yu H., Bharaj B., Vassilikos E.J.K., Giai M., and Diamandis E. Shorter CAG repeat length in the androgen receptor gene is associated with more aggressive forms of breast cancer. Breast Cancer Res Treat 59 (2000) 153-161
36. Iobagiu C., Lambert C., Normand M., and Genin C. Microsatellite profile in hormonal receptor genes associated with breast cancer. Breast Cancer Res Treat 95 (2006) 153-159
37. Nakamura T., Shi D., Tzetis M., Rodriguez-Lopez J., et al. Meta-analysis of association between the ASPN D-repeat and osteoarthritis. Hum Mol Genet 16 (2007) 1676-1681
38. Kristiansen M., Langered A., Knudsen G.P., Weber B.L., Berresen-Dale A.L., and Orstavik K.H. High frequency of skewed X inactivation in young breast cancer patients. J Med Genet 39 (2002) 30-33